Showing results (171-180 of 195) with videos related to
Sort By:
Pageof 20
Human Molecular Genetics|November 5, 1997
Germline mutations of the CDKN2 gene in UK melanoma familiesM Harland, R Meloni, N Gruis, et al.Prostate Cancer and Prostatic Diseases|November 21, 2012
Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancerN Vasiljević, A S Ahmad, C Beesley, et al.British Journal of Cancer|March 19, 2009
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group studyD M Berney, A Gopalan, S Kudahetti, et al.British Journal of Cancer|August 27, 2009
Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangementC S Foster, A R Dodson, L Ambroisine, et al.British Journal of Cancer|February 25, 2012
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohortJ Cuzick, D M Berney, G Fisher, et al.Journal of Epidemiology and Biostatistics|February 2, 2002
Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancerJ Mackay, C Rogers, H Fielder, et al.British Journal of Cancer|June 24, 2015
Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohortJ Cuzick, S Stone, G Fisher, et al.Oncogene|October 9, 2007
Complex patterns of ETS gene alteration arise during cancer development in the human prostateJ Clark, G Attard, S Jhavar, et al.British Journal of Cancer|May 23, 2013
Prognostic value of PTEN loss in men with conservatively managed localised prostate cancerJ Cuzick, Z H Yang, G Fisher, et al.Lancet (London, England)|December 12, 2003
Management of women who test positive for high-risk types of human papillomavirus: the HART studyJ Cuzick, A Szarewski, H Cubie, et al.Pageof 20